Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1105803

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1105803

Lipid Based Formulations Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027 Segmented By Source of Lipids, By Application, By Distribution Channel, By Region

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
PDF and Excel (Multi-User License)
USD 5900
PDF and Excel (Custom Research License)
USD 8900

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The global lipid based formulations market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the rapidly expanding pharmaceutical industry and rising demands for advanced medicines. Besides, the rapidly growing demand for orally administered medicine is expected to boost the global lipid based formulations market.

Lipid-based formulations are bio-chemical compounds synthesized artificially to facilitate drug administration while ensuring drug safety and bio-solubility for digestion and faster action of the main drug component inside the formulation. Lipid-based formulations enable the drug's primary mechanism of action, which leads to bioavailability. In layman's terms, highly water-soluble drugs that dissolve in the beginning of the gut may not reach the target site or target organ, which reduces their efficacy. A lipid-based formulation is used to counteract this effect. Lipids form hydrophobic bonds around the drug, preventing it from dissolving completely or partially until it reaches the target site.

Consistent research and development of drugs to improve bioavailability, effect on the target site, and improve drug facilitation to create its effect at the target site is anticipated to drive the growth of the global lipid based formulations market in the next five years.

Governments in major economies are actively investing in their respective healthcare sectors to improve services and products and provide the best possible patient care. Increased chronic, infectious, and communicable disease prevalence is anticipated to drive growth in the global lipid-based formulations market over the next five years. Consistent research and technological advancement for pharmaceutical product development and advancement of drug delivery systems are also expected to support the growth of the global lipid-based formulations market over the next five years.

The global lipid based formulations market is segmented on the basis of source of lipids, application, distribution channel, regional distribution, and competitive landscape. Based on source of lipids, the market is differentiated between natural and chemically synthesized sources.

Key players operating in the global lipid based formulations market are Novartis AG, AbbVie, Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Alnylam Pharmaceuticals Inc., among others.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023-2027

Objective of the Study:

  • To analyze the historical growth in the market size of the global lipid based formulations from 2017 to 2021.
  • To estimate and forecast the market size of global lipid based formulations market from 2023 to 2027 and growth rate until 2027.
  • To classify and forecast the global lipid based formulations market based on source of liquid, application, distribution channel, region, and company.
  • To identify the dominant region or segment in the global lipid based formulations market.
  • To identify drivers and challenges for the global lipid based formulations market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global lipid based formulations market.
  • To identify and analyze the profiles of leading players operating in the global lipid based formulations market.
  • To identify key sustainable strategies adopted by market players in global lipid based formulations market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of the Global lipid based formulations market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums, and alliances

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global lipid based formulations market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Lipid Based Formulations Market, By Source of Lipids:

Natural

Chemically Synthesized

  • Lipid Based Formulations Market, By Application:

Fungal Diseases

Oncology

Gene Therapy

Antiviral Vaccines

Others

  • Lipid Based Formulations Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

  • Lipid Based Formulations Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global lipid based formulations market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 8209

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Lipid Based Formulations Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Preference, By Source of Lipids
  • 5.2. Factors Contributing to Demand for Lipid Based Formulations
  • 5.3. Barriers to Adoption of Lipid Based Formulations
  • 5.4. Brand Awareness

6. Clinical Trials

  • 6.1. Ongoing Clinical Trials
  • 6.2. Completed Clinical Trials
  • 6.3. Terminated Clinical Trials
  • 6.4. Clinical Trial Analysis

7. Patent Analysis

  • 7.1. Patent Granted (2017-2021)
  • 7.2. Patent Applications Filed

8. List of Commercially Available Lipid Based Formulations

9. Global Lipid Based Formulations Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source of Lipids (Natural v/s Chemically Synthesized)
    • 9.2.2. By Application (Fungal Diseases, Oncology, Gene Therapy, Antiviral Vaccines, Others)
    • 9.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)
    • 9.2.4. By Company (2021)
    • 9.2.5. By Region
  • 9.3. Product Market Map

10. North America Lipid Based Formulations Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source of Lipids
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Lipid Based Formulations Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source of Lipids
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Mexico Lipid Based Formulations Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source of Lipids
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Canada Lipid Based Formulations Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source of Lipids
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Europe Lipid Based Formulations Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Source of Lipids
    • 11.2.2. By Application
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. Europe: Country Analysis
    • 11.3.1. France Lipid Based Formulations Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Source of Lipids
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Germany Lipid Based Formulations Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Source of Lipids
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. United Kingdom Lipid Based Formulations Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Source of Lipids
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Italy Lipid Based Formulations Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Source of Lipids
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Distribution Channel
    • 11.3.5. Spain Lipid Based Formulations Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Source of Lipids
        • 11.3.5.2.2. By Application
        • 11.3.5.2.3. By Distribution Channel

12. Asia-Pacific Lipid Based Formulations Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Source of Lipids
    • 12.2.2. By Application
    • 12.2.3. By Distribution Channel
    • 12.2.4. By Country
  • 12.3. Asia-Pacific: Country Analysis
    • 12.3.1. China Lipid Based Formulations Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Source of Lipids
        • 12.3.1.2.2. By Application
        • 12.3.1.2.3. By Distribution Channel
    • 12.3.2. India Lipid Based Formulations Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Source of Lipids
        • 12.3.2.2.2. By Application
        • 12.3.2.2.3. By Distribution Channel
    • 12.3.3. South Korea Lipid Based Formulations Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Source of Lipids
        • 12.3.3.2.2. By Application
        • 12.3.3.2.3. By Distribution Channel
    • 12.3.4. Japan Lipid Based Formulations Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Source of Lipids
        • 12.3.4.2.2. By Application
        • 12.3.4.2.3. By Distribution Channel
    • 12.3.5. Australia Lipid Based Formulations Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Source of Lipids
        • 12.3.5.2.2. By Application
        • 12.3.5.2.3. By Distribution Channel

13. South America Lipid Based Formulations Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Source of Lipids
    • 13.2.2. By Application
    • 13.2.3. By Distribution Channel
    • 13.2.4. By Country
  • 13.3. South America: Country Analysis
    • 13.3.1. Brazil Lipid Based Formulations Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Source of Lipids
        • 13.3.1.2.2. By Application
        • 13.3.1.2.3. By Distribution Channel
    • 13.3.2. Argentina Lipid Based Formulations Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Source of Lipids
        • 13.3.2.2.2. By Application
        • 13.3.2.2.3. By Distribution Channel
    • 13.3.3. Colombia Lipid Based Formulations Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Source of Lipids
        • 13.3.3.2.2. By Application
        • 13.3.3.2.3. By Distribution Channel

14. Middle East and Africa Lipid Based Formulations Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Source of Lipids
    • 14.2.2. By Application
    • 14.2.3. By Distribution Channel
    • 14.2.4. By Country
  • 14.3. MEA: Country Analysis
    • 14.3.1. South Africa Lipid Based Formulations Market Outlook
      • 14.3.1.1. Market Size & Forecast
        • 14.3.1.1.1. By Value
      • 14.3.1.2. Market Share & Forecast
        • 14.3.1.2.1. By Source of Lipids
        • 14.3.1.2.2. By Application
        • 14.3.1.2.3. By Distribution Channel
    • 14.3.2. Saudi Arabia Lipid Based Formulations Market Outlook
      • 14.3.2.1. Market Size & Forecast
        • 14.3.2.1.1. By Value
      • 14.3.2.2. Market Share & Forecast
        • 14.3.2.2.1. By Source of Lipids
        • 14.3.2.2.2. By Application
        • 14.3.2.2.3. By Distribution Channel
    • 14.3.3. UAE Lipid Based Formulations Market Outlook
      • 14.3.3.1. Market Size & Forecast
        • 14.3.3.1.1. By Value
      • 14.3.3.2. Market Share & Forecast
        • 14.3.3.2.1. By Source of Lipids
        • 14.3.3.2.2. By Application
        • 14.3.3.2.3. By Distribution Channel

15. Market Dynamics

  • 15.1. Drivers
  • 15.2. Challenges

16. Market Trends & Developments

17. Competitive Landscape

  • 17.1. Novartis AG
  • 17.2. AbbVie, Inc.
  • 17.3. F. Hoffmann-La Roche AG
  • 17.4. Johnson & Johnson
  • 17.5. Alnylam Pharmaceuticals Inc.

18. Strategic Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!